Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru




COVID-19, Hospitalization, Intensive Care Units, Mortality, Child, Peru


This study aimed to describe the characteristics of pediatric patients (28 days to 14 years of age) hospitalized with COVID-19 during the third wave of the pandemic (omicron variant) at the Hospital Nacional Edgardo Rebagliati Martins (HNERM) (Lima, Peru). In this retrospective cohort, we reviewed the medical records of 122 pediatric patients who attended HNERM between January and early April 2022 (55% male, median age: 5 years); 77.9% attended HNERM during the first month, and half of them had some comorbidity. Participants were hospitalized mainly for respiratory distress, decompensated comorbidity, and dehydration. Of the participants, 6.6% were admitted to intensive care, 4.9% to invasive mechanical ventilation, 5.7% required some vasoactive agent and 1.6% died. The most commonly used drugs were antibiotics (43.4%) and corticosteroids (27.1%). In conclusion, hospitalizations rapidly increased during the third wave, when compared to previous waves, most of them with favorable progression and with a wide empirical use of antibiotics. 


Download data is not yet available.


Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis. PloS one. 2021;16(2):e0246318. doi: 10.1371/journal.pone.0246318.

Ma X, Liu S, Chen L, Zhuang L, Zhang J, Xin Y. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: A meta-analysis and systematic review. J Med Virol. 2021;93(1):234-40. doi: 10.1002/jmv.26208.

Alvarado-Gamarra G, del Aguila O, Dominguez-Rojas J, Chonlon-Murillo K, Atamari-Anahui N, Borcic A, et al. Fenotipos clínicos del síndrome inflamatorio multisistémico pediátrico asociado a COVID-19 (SIM-C). Andes Pediatrica. 2022;93(6): 841-850. doi: 10.32641/andespediatr.v93i6.4084.

Toyama M, Vargas L, Ticliahuanca S, Quispe AM. Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru. Gates Open Res. 2022;6(74):74. doi: 10.1016/j.annepidem.2022.08.026.

Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health. 2022;6(5):294-302. doi: 10.1016/S2352-4642(22)00027-X.

Marks KJ, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, et al. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):271-8. doi: 10.15585/mmwr.mm7107e4.

Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM, et al. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):146-52. doi: 10.15585/mmwr.mm7104e4.

Taytard J, Prevost B, Schnuriger A, Aubertin G, Berdah L, Bitton L, et al. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant. Front Pediatr. 2022;10:932170. doi: 10.3389/fped.2022.932170.

Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. JAMA Pediatr. 2022;176(8):811-3. doi: 10.1001/jamapediatrics.2022.0945.

Butt AA, Dargham SR, Loka S, Shaik RM, Chemaitelly H, Tang P, et al. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant. Clin Infect Dis. 2022;75(1):e361-e7. doi: 10.1093/cid/ciac275.

Molina Gutiérrez M, Sánchez Trujillo L, Ruiz Domínguez JA, Callejas Caballero I, García Cuartero B, García-Herrero M, et al. Clinical Characteristics of Omicron (B.1.1.529) Variant in Children: A Multicenter Study in Spain. Arch Bronconeumol. 2022;58(9):669-71. doi: 10.1016/j.arbres.2022.06.001.

The Lancet. COVID-19 in Latin America-emergency and opportunity. Lancet (London, England). 2021;398(10295):93. doi: 10.1016/S0140-6736(21)01551-8.

Valladares-Garrido MJ, Failoc-Rojas VE, Soto-Becerra P, Zeña-Ñañez S, Torres-Roman JS, Fernández-Mogollón JL, et al. Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis. Int J Infect Dis. 2022;123:212-220. doi: 10.1016/j.ijid.2022.07.045.

Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276-e288. doi: 10.1016/S1473-3099(20)30651-4.

Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum. 2015;44(4):405-10. doi: 10.1016/j.semarthrit.2014.07.007.

Acker KP, Levine DA, Varghese M, Nash KA, RoyChoudhury A, Abramson EL, et al. Indications for Hospitalization in Children with SARS-CoV-2 Infection during the Omicron Wave in New York City. Children (Basel). 2022;9(7):1043. doi: 10.3390/children9071043.

Tso WWY, Kwan MYW, Wang YL, Leung LK, Leung D, Chua GT, et al. Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated

hospitalized children: comparison to influenza and parainfluenza infections. Emerg Microbes Infect. 2022;11(1):1742-50. doi:


Choi YY, Kim YS, Lee SY, Sim J, Choe YJ, Han MS. Croup as a Manifestation of SARS-CoV-2 Omicron Variant Infection in Young Children. J Korean Med Sci. 2022;37(20):e140. doi: 10.3346/jkms.2022.37.e140.

Domínguez Rojas J, Estupiñan Vigil M, Garcés-Ghilardi R, Alvarado-Gamarra G, Del Águila O, Lope Tenorio AF, et al. [Cross-sectional study of the clinical characteristics and outcomes of children hospitalized with COVID-19 in Lima, Peru]. Medwave. 2021;21(1):e8107. doi: 10.5867/medwave.2021.01.8107.

Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020:ciaa478. doi: 10.1093/cid/ciaa478.

Fraile Navarro D, McMullan B, Bowen AC. Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce. Med J Aust. 2022;216(9):489. doi: 10.5694/mja2.51510.

Instituto de Evaluación de Tecnologías en Salud e Investigación. Guía de Práctica Clínica para el Manejo de COVID-19 en Pediatría: Guía en Versión Extensa. Versión 1, Enero 2022. Lima: EsSalud; 2022. Diponible en:





Brief Report

How to Cite

Alvarado-Gamarra G, Zarate-Campos V, Saavedra Díaz JA, Sánchez Julca RM, Tahua Vega A, Borcic A, et al. Characteristics of pediatric patients hospitalized with COVID-19 during the third wave (omicron variant) at a referral hospital in Peru. Rev Peru Med Exp Salud Publica [Internet]. 2023 Jun. 30 [cited 2024 Jun. 12];40(2):200-6. Available from:

Most read articles by the same author(s)

1 2 > >>